January 2015 Florida Blue Utilization Management Update
Transcription
January 2015 Florida Blue Utilization Management Update
January 2015 Commercial and Other Pharmacy Program Updates Effective Jan. 1, 2015 Several changes to Florida Blue’s Pharmacy Programs will be implemented Jan. 1, 2015. The modifications affect medications that require prior authorization, the Responsible Steps Program, the Responsible Quantity Program and the pharmacy coverage exclusions list. The changes are included below. Pharmacy Coverage Exclusion Addition Effective Jan. 1, 2015, Florida Blue commercial pharmacy plans will no longer cover the brand name drugs listed in the table below. However, Florida Blue will cover many of their generic alternatives. This exclusion list only applies to members in plans that allow pharmacy coverage exclusions. Drugs Not Covered Covered Alternatives Active Prep Kit Oral generic versions of the components Apidra, Humalog, Humalog Mix50/50, Humalog Mix75/25, Humulin R U-100, Humulin 70/30, Humulin N Novolog, Novolog Mix 70/30, Novolin R, Novolin N Novolin 70/30, Lantus, Levemir, Humulin R U-500 Deprizine fusepaq ranitidine Jublia Ciclopirox nail lacquer Natesto, Vogelxo, Androderm, Androgel NP #2 Drug preparation kit Oral generic versions of the components Panoxyl Benzoyl Peroxide (Rx only) Sitavig Acyclovir Synapryn fusepak Tramadol generic Tramadol ER brand Tramadol ER generic Responsible Steps Additions Beginning Jan. 1, 2015, Florida Blue will add the following list of drugs to the Responsible Steps Program for members enrolled in our under 65 products. This only applies to members enrolled in health plans that are part of the Responsible Steps Program. Program New Target Diabetes Step Trulicity 900-524-1114 Medications Requiring Prior Authorization Prior authorization requirements for the following list of medications will changeunder the member’s pharmacy benefit effective Jan. 1, 2015. This only applies to members enrolled in plans that are part of the Prior Authorization Program. Drugs Added to the Prior Authorization Program Drug Coverage Criteria* Apidra, Humalog, Humalog Mix Trial and failure or contraindication to a therapeutically products, Humulin R U-100, equivalent product from the following list: Novolog, Novolog Humulin 70/30, Humulin N** Mix 70/30, Novolin R, Novolin N, Novolin 70/30 or Levemir, Non-preferred glucose test strips Concurrent use of an insulin pump that does not integrate with (all strips except Bayer strips) Bayer meters Beleodaq Relapsed or refractory T cell Lymphoma Bunavail Treatment of opioid dependence Cerdelga Treatment of Gaucher’s disease Esbriet Treatment of idiopathic pulmonary fibrosis Harvoni Treatment of Hepatitis C infection Jublia Treatment of fungal infection Kerydin Treatment of fungal infection Keytruda Treatment of melanoma Natesto Treatment of male hypogonadism Ofev Treatment of idiopathic pulmonary fibrosis Plegridy Prevention of Multiple Sclerosis exacerbations Ruconest Treatment of acute attacks of hereditary angioedema Sivextro Treatment of resistant gram positive infections Terbinex Treatment of fungal infection Testosterone Pump Treatment of male hypogonadism Zydelig Treatment of Leukemia or Lymphoma *Summary of criteria, see http://mcgs.bcbsfl.com for complete criteria information. **Prior authorization for non-preferred insulins only apply to members in plans that allow Prior Authorization but do not allow Coverage Exclusion. Responsible Quantity Additions The following list of drugs and drug dispensing limits will be added to the Responsible Quantity Program, Oct. 1, 2014. This only applies to members enrolled in in health plans that are part of the Responsible Quantity Program. Please note: Responsible Quantity Program limits apply to generic drugs where applicable and to members enrolled in health plans that are part of the Responsible Quantity Program. 900-524-1114 2 Brand/Generic Name Strength Dispensing Limit Per Month (unless otherwise noted) New Drugs to the Program Bunavail 2.1/03mg, 4.2/0.7mg 30 films Bunavail 6.3/1mg 60 films Buphenyl powder 600 gm Buphenyl 500 mg tablet 1200 tablets 7.5 mcg/hr 4 patches / 28 days Butrans Cerdelga 60 caps Esbriet 270 caps Myalept 30 vials Ofev 60 caps Plegridy Plegridy 2 pens / 28 days Starter kit Ravicti Revatio 1 kit / 180 days 525 ml 10mg / ml suspension Sivextro 224 ml 6 tabs Testosterone Pump 2 pumps Triumeq 30 tabs Trulicity 4 pens/28 days Tybost 30 tabs Xarelto 1 kit Zydelig 60 tabs Authorization Request forms Authorization request forms are available at www.floridablue.com. Click on the Providers box, and then click Pharmacy. A listing of the programs and authorization forms can be found there. Pharmacy Preferred Drug List Changes and Current Listing Changes to our preferred drug lists as well as a current listing is available at www.floridablue.com. Click on the Providers tab, Pharmacy Information and Resources, and then the Medication Guides link. To request a written copy of materials posted to our website, please contact our Provider Contact Center at (800) 727-2227. 900-524-1114 3